Do analysts rate LUNG or OSRH?

Pulmonx currently has a consensus price target of $5.58, suggesting a potential upside of 318.23%. Given Pulmonx's stronger consensus rating and higher probable upside, equities analysts clearly believe Pulmonx is more favorable than OSR. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pulmonx 1 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.43 OSR 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings and valuation, LUNG or OSRH?

OSR has lower revenue, but higher earnings than Pulmonx. OSR is trading at a lower price-to-earnings ratio than Pulmonx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Pulmonx $90.50M 0.62 -$54M -$1.30 N/A OSR $2.91M 4.23 -$27.06M -$0.33 N/A

Is LUNG or OSRH more profitable?

Pulmonx has a net margin of -60.09% compared to OSR's net margin of -363.26%. OSR's return on equity of -7.24% beat Pulmonx's return on equity. Company Net Margins Return on Equity Return on Assets Pulmonx -60.09% -92.94% -39.80% OSR -363.26% -7.24% -5.41%

Does the media favor LUNG or OSRH?

In the previous week, Pulmonx had 1 more articles in the media than OSR. MarketBeat recorded 2 mentions for Pulmonx and 1 mentions for OSR. OSR's average media sentiment score of 0.51 beat Pulmonx's score of 0.00 indicating that OSR is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pulmonx 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral OSR 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend DRIO or OSRH?

DarioHealth currently has a consensus price target of $10.50, suggesting a potential upside of 64.29%. Given DarioHealth's stronger consensus rating and higher possible upside, analysts plainly believe DarioHealth is more favorable than OSR. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DarioHealth 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 OSR 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings and valuation, DRIO or OSRH?

OSR has lower revenue, but higher earnings than DarioHealth. OSR is trading at a lower price-to-earnings ratio than DarioHealth, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio DarioHealth $22.36M 2.09 -$41.71M -$8.88 N/A OSR $2.91M 4.23 -$27.06M -$0.33 N/A

Is DRIO or OSRH more profitable?

DarioHealth has a net margin of -192.23% compared to OSR's net margin of -363.26%. OSR's return on equity of -7.24% beat DarioHealth's return on equity. Company Net Margins Return on Equity Return on Assets DarioHealth -192.23% -60.52% -37.08% OSR -363.26% -7.24% -5.41%

Do analysts prefer OSRH or SKYA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OSR 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SkyAI, Inc. Common Stock 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation and earnings, OSRH or SKYA?

OSR has higher revenue and earnings than SkyAI, Inc. Common Stock. OSR is trading at a lower price-to-earnings ratio than SkyAI, Inc. Common Stock, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio OSR $2.91M 4.23 -$27.06M -$0.33 N/A SkyAI, Inc. Common Stock $396.90K 109.83 -$282.50M -$1.63 N/A

Is OSRH or SKYA more profitable?

SkyAI, Inc. Common Stock has a net margin of 0.00% compared to OSR's net margin of -363.26%. OSR's return on equity of -7.24% beat SkyAI, Inc. Common Stock's return on equity. Company Net Margins Return on Equity Return on Assets OSR -363.26% -7.24% -5.41% SkyAI, Inc. Common Stock N/A -157.91% -154.40%

Do analysts rate OSRH or COCH?

Envoy Medical has a consensus price target of $2.50, suggesting a potential upside of 290.02%. Given Envoy Medical's stronger consensus rating and higher possible upside, analysts plainly believe Envoy Medical is more favorable than OSR. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OSR 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Envoy Medical 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has stronger valuation and earnings, OSRH or COCH?

Envoy Medical has lower revenue, but higher earnings than OSR. OSR is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio OSR $2.91M 4.23 -$27.06M -$0.33 N/A Envoy Medical $240K 205.33 -$23.76M -$1.01 N/A

Is OSRH or COCH more profitable?

OSR has a net margin of -363.26% compared to Envoy Medical's net margin of -9,875.64%. Envoy Medical's return on equity of 0.00% beat OSR's return on equity. Company Net Margins Return on Equity Return on Assets OSR -363.26% -7.24% -5.41% Envoy Medical -9,875.64% N/A -177.92%

Does the media prefer OSRH or COCH?

In the previous week, OSR and OSR both had 1 articles in the media. OSR's average media sentiment score of 0.51 beat Envoy Medical's score of 0.00 indicating that OSR is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OSR 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Envoy Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate SRTS or OSRH?

Sensus Healthcare currently has a consensus price target of $6.88, indicating a potential upside of 151.83%. Given Sensus Healthcare's stronger consensus rating and higher probable upside, analysts plainly believe Sensus Healthcare is more favorable than OSR. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sensus Healthcare 1 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.57 OSR 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings and valuation, SRTS or OSRH?

Sensus Healthcare has higher revenue and earnings than OSR. Sensus Healthcare is trading at a lower price-to-earnings ratio than OSR, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sensus Healthcare $27.48M 1.64 -$7.72M -$0.47 N/A OSR $2.91M 4.23 -$27.06M -$0.33 N/A

Is SRTS or OSRH more profitable?

Sensus Healthcare has a net margin of -34.50% compared to OSR's net margin of -363.26%. OSR's return on equity of -7.24% beat Sensus Healthcare's return on equity. Company Net Margins Return on Equity Return on Assets Sensus Healthcare -34.50% -15.79% -14.02% OSR -363.26% -7.24% -5.41%

OSR (OSRH) Competitors

$0.35 -0.01 (-2.77%)

As of 11:15 AM Eastern

Compare

OSRH vs. LUNG, DRIO, SKYA, COCH, and SRTS

Should you buy OSR stock or one of its competitors? MarketBeat compares OSR with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with OSR include Pulmonx (LUNG), DarioHealth (DRIO), SkyAI, Inc. Common Stock (SKYA), Envoy Medical (COCH), and Sensus Healthcare (SRTS). These companies are all part of the "medical equipment" industry.

How does OSR compare to Pulmonx?

Pulmonx (NASDAQ:LUNG) and OSR (NASDAQ:OSRH) are both small-cap medical equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, earnings, valuation, risk, profitability and dividends.

Pulmonx currently has a consensus price target of $5.58, suggesting a potential upside of 318.23%. Given Pulmonx's stronger consensus rating and higher probable upside, equities analysts clearly believe Pulmonx is more favorable than OSR.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pulmonx	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43
OSR	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

91.0% of Pulmonx shares are held by institutional investors. Comparatively, 55.3% of OSR shares are held by institutional investors. 6.8% of Pulmonx shares are held by company insiders. Comparatively, 36.8% of OSR shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Pulmonx had 1 more articles in the media than OSR. MarketBeat recorded 2 mentions for Pulmonx and 1 mentions for OSR. OSR's average media sentiment score of 0.51 beat Pulmonx's score of 0.00 indicating that OSR is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pulmonx	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
OSR	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

OSR has lower revenue, but higher earnings than Pulmonx. OSR is trading at a lower price-to-earnings ratio than Pulmonx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pulmonx	$90.50M	0.62	-$54M	-$1.30	N/A
OSR	$2.91M	4.23	-$27.06M	-$0.33	N/A

Pulmonx has a beta of 0.28, indicating that its stock price is 72% less volatile than the broader market. Comparatively, OSR has a beta of 0.61, indicating that its stock price is 39% less volatile than the broader market.

Pulmonx has a net margin of -60.09% compared to OSR's net margin of -363.26%. OSR's return on equity of -7.24% beat Pulmonx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pulmonx	-60.09%	-92.94%	-39.80%
OSR	-363.26%	-7.24%	-5.41%

Summary

Pulmonx and OSR tied by winning 8 of the 16 factors compared between the two stocks.

How does OSR compare to DarioHealth?

DarioHealth (NASDAQ:DRIO) and OSR (NASDAQ:OSRH) are both small-cap medical equipment companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, risk, institutional ownership, analyst recommendations, dividends, valuation, earnings and profitability.

In the previous week, OSR had 1 more articles in the media than DarioHealth. MarketBeat recorded 1 mentions for OSR and 0 mentions for DarioHealth. DarioHealth's average media sentiment score of 1.00 beat OSR's score of 0.51 indicating that DarioHealth is being referred to more favorably in the media.

Company	Overall Sentiment
DarioHealth	Positive
OSR	Positive

OSR has lower revenue, but higher earnings than DarioHealth. OSR is trading at a lower price-to-earnings ratio than DarioHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DarioHealth	$22.36M	2.09	-$41.71M	-$8.88	N/A
OSR	$2.91M	4.23	-$27.06M	-$0.33	N/A

DarioHealth has a beta of 1.11, indicating that its stock price is 11% more volatile than the broader market. Comparatively, OSR has a beta of 0.61, indicating that its stock price is 39% less volatile than the broader market.

DarioHealth currently has a consensus price target of $10.50, suggesting a potential upside of 64.29%. Given DarioHealth's stronger consensus rating and higher possible upside, analysts plainly believe DarioHealth is more favorable than OSR.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DarioHealth	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
OSR	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

DarioHealth has a net margin of -192.23% compared to OSR's net margin of -363.26%. OSR's return on equity of -7.24% beat DarioHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DarioHealth	-192.23%	-60.52%	-37.08%
OSR	-363.26%	-7.24%	-5.41%

33.4% of DarioHealth shares are held by institutional investors. Comparatively, 55.3% of OSR shares are held by institutional investors. 3.5% of DarioHealth shares are held by company insiders. Comparatively, 36.8% of OSR shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

DarioHealth and OSR tied by winning 8 of the 16 factors compared between the two stocks.

How does OSR compare to SkyAI, Inc. Common Stock?

OSR (NASDAQ:OSRH) and SkyAI, Inc. Common Stock (NASDAQ:SKYA) are both small-cap medical equipment companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

In the previous week, OSR had 1 more articles in the media than SkyAI, Inc. Common Stock. MarketBeat recorded 1 mentions for OSR and 0 mentions for SkyAI, Inc. Common Stock. OSR's average media sentiment score of 0.51 beat SkyAI, Inc. Common Stock's score of 0.00 indicating that OSR is being referred to more favorably in the media.

Company	Overall Sentiment
OSR	Positive
SkyAI, Inc. Common Stock	Neutral

OSR has higher revenue and earnings than SkyAI, Inc. Common Stock. OSR is trading at a lower price-to-earnings ratio than SkyAI, Inc. Common Stock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OSR	$2.91M	4.23	-$27.06M	-$0.33	N/A
SkyAI, Inc. Common Stock	$396.90K	109.83	-$282.50M	-$1.63	N/A

55.3% of OSR shares are owned by institutional investors. Comparatively, 17.2% of SkyAI, Inc. Common Stock shares are owned by institutional investors. 36.8% of OSR shares are owned by insiders. Comparatively, 20.0% of SkyAI, Inc. Common Stock shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

SkyAI, Inc. Common Stock has a net margin of 0.00% compared to OSR's net margin of -363.26%. OSR's return on equity of -7.24% beat SkyAI, Inc. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OSR	-363.26%	-7.24%	-5.41%
SkyAI, Inc. Common Stock	N/A	-157.91%	-154.40%

OSR has a beta of 0.61, suggesting that its stock price is 39% less volatile than the broader market. Comparatively, SkyAI, Inc. Common Stock has a beta of 2.04, suggesting that its stock price is 104% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OSR	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
SkyAI, Inc. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

OSR beats SkyAI, Inc. Common Stock on 9 of the 13 factors compared between the two stocks.

How does OSR compare to Envoy Medical?

OSR (NASDAQ:OSRH) and Envoy Medical (NASDAQ:COCH) are both small-cap medical equipment companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, risk, dividends, media sentiment, valuation and profitability.

In the previous week, OSR and OSR both had 1 articles in the media. OSR's average media sentiment score of 0.51 beat Envoy Medical's score of 0.00 indicating that OSR is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OSR	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Envoy Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Envoy Medical has lower revenue, but higher earnings than OSR. OSR is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OSR	$2.91M	4.23	-$27.06M	-$0.33	N/A
Envoy Medical	$240K	205.33	-$23.76M	-$1.01	N/A

Envoy Medical has a consensus price target of $2.50, suggesting a potential upside of 290.02%. Given Envoy Medical's stronger consensus rating and higher possible upside, analysts plainly believe Envoy Medical is more favorable than OSR.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OSR	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

55.3% of OSR shares are held by institutional investors. Comparatively, 8.6% of Envoy Medical shares are held by institutional investors. 36.8% of OSR shares are held by insiders. Comparatively, 7.1% of Envoy Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

OSR has a beta of 0.61, meaning that its stock price is 39% less volatile than the broader market. Comparatively, Envoy Medical has a beta of 1.9, meaning that its stock price is 90% more volatile than the broader market.

OSR has a net margin of -363.26% compared to Envoy Medical's net margin of -9,875.64%. Envoy Medical's return on equity of 0.00% beat OSR's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OSR	-363.26%	-7.24%	-5.41%
Envoy Medical	-9,875.64%	N/A	-177.92%

Summary

Envoy Medical beats OSR on 8 of the 15 factors compared between the two stocks.

How does OSR compare to Sensus Healthcare?

Sensus Healthcare (NASDAQ:SRTS) and OSR (NASDAQ:OSRH) are both small-cap medical equipment companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, risk, profitability, analyst recommendations, earnings and institutional ownership.

Sensus Healthcare has a beta of 1.09, suggesting that its stock price is 9% more volatile than the broader market. Comparatively, OSR has a beta of 0.61, suggesting that its stock price is 39% less volatile than the broader market.

Sensus Healthcare has a net margin of -34.50% compared to OSR's net margin of -363.26%. OSR's return on equity of -7.24% beat Sensus Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sensus Healthcare	-34.50%	-15.79%	-14.02%
OSR	-363.26%	-7.24%	-5.41%

In the previous week, OSR had 1 more articles in the media than Sensus Healthcare. MarketBeat recorded 1 mentions for OSR and 0 mentions for Sensus Healthcare. OSR's average media sentiment score of 0.51 beat Sensus Healthcare's score of 0.00 indicating that OSR is being referred to more favorably in the news media.

Company	Overall Sentiment
Sensus Healthcare	Neutral
OSR	Positive

Sensus Healthcare currently has a consensus price target of $6.88, indicating a potential upside of 151.83%. Given Sensus Healthcare's stronger consensus rating and higher probable upside, analysts plainly believe Sensus Healthcare is more favorable than OSR.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sensus Healthcare	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
OSR	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Sensus Healthcare has higher revenue and earnings than OSR. Sensus Healthcare is trading at a lower price-to-earnings ratio than OSR, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sensus Healthcare	$27.48M	1.64	-$7.72M	-$0.47	N/A
OSR	$2.91M	4.23	-$27.06M	-$0.33	N/A

25.3% of Sensus Healthcare shares are owned by institutional investors. Comparatively, 55.3% of OSR shares are owned by institutional investors. 10.2% of Sensus Healthcare shares are owned by insiders. Comparatively, 36.8% of OSR shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

OSR beats Sensus Healthcare on 9 of the 16 factors compared between the two stocks.

Get OSR News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OSRH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

OSRH vs. The Competition

Export

Metric	OSR	UNCLASSIFIED Industry	Manufacturing Sector	NASDAQ Exchange
Market Cap	$12.32M	$151.46M	$4.34B	$12.21B
Dividend Yield	N/A	N/A	10.93%	5.83%
P/E Ratio	-1.06	43.76	22.09	24.15
Price / Sales	4.23	243.80	150.48	122.48
Price / Cash	N/A	2,312.00	40.77	54.51
Price / Book	0.07	39.23	16.91	6.51
Net Income	-$27.06M	-$20.48M	$115.37M	$337.14M
7 Day Performance	-8.64%	-0.41%	-0.42%	0.21%
1 Month Performance	-30.08%	-1.26%	-1.60%	1.17%
1 Year Performance	-72.58%	4.67%	11.92%	28.90%

OSR Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
OSRH OSR	1.0442 of 5 stars	$0.35 -2.8%	N/A	-72.4%	$12.32M	$2.91M	N/A	N/A
LUNG Pulmonx	1.7907 of 5 stars	$1.28 -0.4%	$5.58 +337.9%	-50.2%	$54.06M	$90.50M	N/A	250	News Coverage
DRIO DarioHealth	2.6732 of 5 stars	$6.93 flat	$10.50 +51.5%	-56.3%	$50.67M	$22.36M	N/A	200	Positive News Gap Down
SKYA SkyAI, Inc. Common Stock	0.8369 of 5 stars	$1.18 flat	N/A	-80.7%	$49.94M	$200K	N/A	55	Gap Up High Trading Volume
COCH Envoy Medical	2.0828 of 5 stars	$0.63 flat	$2.50 +294.3%	-53.6%	$48.74M	$240K	N/A	34	News Coverage High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:OSRH) was last updated on 6/24/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

OSR (OSRH) Competitors